Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04209114
What this trial is testing

Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Who this might be right for
Bladder CancerBladder TumorMuscle-Invasive Bladder Cancer
Bristol-Myers Squibb 114
Not applicableStudy completedNCT05297604
What this trial is testing

Non-Invasive Intravascular Laser Irradiation Of Blood In The Treatment Of Children With Temporomandibular Disorders

Who this might be right for
Temporomandibular Disorder
University of Nove de Julho 56
Large-scale testing (Phase 3)UnknownNCT03664869
What this trial is testing

Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Turku University Hospital 300
Large-scale testing (Phase 3)Active Not RecruitingNCT04960709
What this trial is testing

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

Who this might be right for
Muscle Invasive Bladder Cancer
AstraZeneca 712
Testing effectiveness (Phase 2)Study completedNCT00322699
What this trial is testing

Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
North Florida/South Georgia Veterans Health System 22
Large-scale testing (Phase 3)UnknownNCT05822934
What this trial is testing

Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer

Who this might be right for
Urinary Bladder Cancer
Assiut University 20
Not applicableStudy completedNCT04321707
What this trial is testing

Complete Local Response to Neoadjuvant Chemotherapy in Patients With Muscle Invasive Bladder Cancer Evaluated by 15O-H2O PET/MR

Who this might be right for
Bladder Cancer
Jørgen Bjerggaard Jensen 13
Early research (Phase 1)Study completedNCT03171493
What this trial is testing

Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy

Who this might be right for
Urothelial Carcinoma
Vyriad, Inc. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05316155
What this trial is testing

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 235
Not applicableLooking for participantsNCT05672615
What this trial is testing

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Johns Hopkins University 42
Not applicableStudy completedNCT01946178
What this trial is testing

Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids

Who this might be right for
Uterine Fibroids (Leiomyomas)
Mirabilis Medica, Inc. 73
Testing effectiveness (Phase 2)Looking for participantsNCT06732531
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerNon Muscle Invasive
Zhuhai Beihai Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT02007005
What this trial is testing

Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Abnoba Gmbh 37
Very early researchEnrolling By InvitationNCT06204614
What this trial is testing

Drug Screening Using IMD in Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Urothelial Carcinoma
Brigham and Women's Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06682728
What this trial is testing

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

Who this might be right for
Urothelial CarcinomaMuscle-invasive Bladder Cancer
University of California, Irvine 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04375813
What this trial is testing

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Who this might be right for
Non-muscle Invasive Bladder Cancer
Robert Svatek 166
Not applicableStudy completedNCT02861196
What this trial is testing

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59
Early research (Phase 1)Study completedNCT03404791
What this trial is testing

TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 35
Early research (Phase 1)Study completedNCT05085990
What this trial is testing

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 10
Large-scale testing (Phase 3)Looking for participantsNCT07000084
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Who this might be right for
Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8
Alliance for Clinical Trials in Oncology 330
Next Page